SECsense Logo

Cumberland Pharmaceuticals Inc. 8-K Report: Key Insights and Filing Details

$CPIX
Form 8-K
Filed on: 2025-02-19
Source
Cumberland Pharmaceuticals Inc. 8-K Report: Key Insights and Filing Details

Based on the provided XML section of the financial report, here are the key insights and information extracted:

  1. Entity Information:
  • Company Name: Cumberland Pharmaceuticals Inc.
  • Location: 1600 West End Avenue, Suite 1300, Nashville, TN 37203.
  • Phone Number: 615-255-0068.
  • CIK (Central Index Key): 0001087294.
  • IRS Employer Identification Number (EIN): 62-1765329.
  1. Filing Details:
  • Filing Type: 8-K (Current Report).
  • Filing Date: February 19, 2025.
  • SEC File Number: 001-33637.
  1. Stock Information:
  • Type of Stock: Common Stock, no par value.
  • Ticker Symbol: CPIX (listed on NASDAQ).
  1. Reporting Context:
  • Reporting Period: The report covers a specific date, February 19, 2025.
  1. XBRL and Schema Information:
  • XBRL Version: The report is in XBRL format, which is used for the electronic filing of financial reports with the SEC.
  • Schema Reference: The document references a specific schema file (cpix-20250219.xsd).

Summary

This section of the financial report provides essential details about Cumberland Pharmaceuticals Inc., including its corporate identifiers, filing details, nature of stock, and the reporting date. The 8-K filing indicates important events or changes that the company is required to report to the SEC. The use of XBRL suggests that this report is compliant with modern electronic filing standards.